| 영문 | amino acids | 한글 | 아미노산 |
|---|---|---|---|
| 설명 | 아미노기(－NH3)와 카르복실기(－COOH)를 가지고 있는 모든 유기물질. 단백질을 이루는 기본단위가 된다. 즉 단백질은 아미노산이 연결되어서 이루는 것이다. 인체에서는 아미노산이 단백질의 기본단위가 되는 것외에 신경세포와 신경세포가 서로 연락을 주고 받는데 쓰이는 신경전달물질로서의 역할도 한다. 사람의 단백질은 20가지의 아미노산으로 구성된다. 즉 사람에 있어서 단백질을 합성하는 데는 20가지의 아미노산이 필요하다. 여기에서 11가지는 인체내에서 직접 합성할 수 있지만 나머지 9가지는 합성할 수 없고 반드시 음식물에서 섭취해야 한다. 이것을 필수아미노산이라고 한다. |
||
| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| ADD | acceptable daily dose; adduction; adenosine deaminase; attentional deficit disorder; average daily d... |
| ADI | Academy of Dentistry International; acceptable daily intake; AIDS-defining illness; allowable daily ... |
| DRF | Daily Rating Form; daily replacement factor; Deafness Research Foundation; dose reduction factor |
| AAN | AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o... |
| ADI | Acceptable Daily Intake |
|---|---|
| ADL | Activities of Daily Life |
| ADL | Activities of Daily Living |
| ADLs | Activities of Daily Living |
| ADVS | Activities of Daily Vision Scale |
para-amino salicylic acid
| acceptable daily intake | <pharmacology> This is an estimate of the amount of a substance in food that can be ingested daily over a lifetime by humans without appreciable health risk. The concept of the acceptable daily intake has been developed principally by who and FAO and is relevant to chemicals such as additives to foods, residues of pesticides and veterinary drugs in foods. Acceptable daily intakes are derived from laboratory toxicity data, and from human experiences of such chemicals when this is available, and incorporate a safety factor. The acceptable daily intake is thus an estimate of the amount of a substance in food that can be ingested over a lifetime by humans without significant risk to health (for contaminants in food and drinking water, tolerable intakes - daily or weekly - are used). See: tolerable daily intake. (15 Jan 1998) |
|---|---|
| activities of daily living | The things we normally do in daily living including any daily activity we perform for self-care (such as feeding ourselves, bathing, dressing, grooming), work, homemaking, and leisure. The ability or inability to perform ADLs can be used as a very practical measure of ability/disability in many disorders. (12 Dec 1998) |
| activities of daily living scale | A scale to score physical activity and its limitations, based on answers to simple questions about mobility, self-care, grooming, etc; widely used in geriatrics, rheumatology, etc. (05 Mar 2000) |
| daily dose | The total amount of a remedy that is to be taken within 24 hours. (05 Mar 2000) |
| tolerable daily intake | TDIs are applied to chemical contaminants in food and drinking water. The presence of contaminants is unwanted and they have no useful function, differing from additives and residues where there is or was deliberate use resulting in their presence. TDIs are calculated on the basis of laboratory toxicity data with the application of uncertainty factors. A TDI is therefore an estimate of the amount of a substance (contaminant) in food or drinking water that can be ingested daily over a lifetime without a significant health risk. (09 Oct 1997) |
| acidic amino acid | An Amino acid with a second acid moiety, e.g., glutamic acid, aspartic acid, cysteic acid. (05 Mar 2000) |
| activated amino acid | The product formed by the condensation of the acyl radical of an amino acid and adenosine 5'-monophosphate (originally in the form of adenosine 5'-triphosphate, with elimination of a pyrophosphoric group). Formed in the first step of protein biosynthesis. Synonym: activated amino acid. (05 Mar 2000) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | <chemical> Alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An ibotenic acid homolog and glutamate agonist. The compound is the defining agonist for the ampa subtype of glutamate receptors (receptors, ampa). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. Pharmacological action: excitatory amino acid agonists. Chemical name: 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo- (12 Dec 1998) |
| alpha-amino acid | Typically, an amino acid of the general formula R-CHNH2-COOH (i.e., the NH2 in the a position); the l forms of these are the hydrolysis products of proteins. In rarer usages, this class of molecules also includes alpha-amino phosphoric acids and alpha-aminosulfonic acids. (05 Mar 2000) |
| alpha-amino acid esterase | <enzyme> Converts alpha-amino acid esters and water to alpha-amino acids and alcohol Registry number: EC 3.1.1.43 Synonym: alpha-amino acid ester hydrolase (26 Jun 1999) |
| alpha-amino-beta-ketoadipic acid | 2-Amino-3-oxo-1,6-hexanedioic acid;an intermediate of porphobilinogen synthesis formed by d-aminolevulinic acid synthase from succinyl-CoA and glycine; it rapidly decarboxylates to d-aminolevulinic acid. (05 Mar 2000) |
| amino- | <prefix> Prefix denoting a compound containing the radical, -NH2. Origin: an(monia) + in(e) + -o- (05 Mar 2000) |
| amino acid | <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms. There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA. All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains. There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins. Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation. Acronym: AA (13 Nov 1997) |
| amino acid activating enzyme | <enzyme> Enzymes catalyzing the formation of a specific aminoacyl-tRNA from an amino acid and adenosine 5'-triphosphate with the concomitant formation of adenosine 5'-monophosphate and pyrophosphate. Synonym: amino acid activating enzyme, aminoacyl-tRNA ligases. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|